🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is being conducted to evaluate the safety and efficacy of tisleli...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2023-12-01
Trial ID
NCT06177301
Treatments Being Tested
Cholangiocarcinoma (CCA) is a heterogeneous group of cancers arising from t...
Status
Recruiting
Location
The Second Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2022-01-31
Trial ID
NCT05532059
Treatments Being Tested
The purpose of this study is to explore the efficacy and safety of a combin...
Status
Active Not Recruiting
Location
The Affiliated Hospital of Guangdong Medical College
Start Date
2022-06-10
Trial ID
NCT05211232
Treatments Being Tested
This is an open label, multi-center, phaseⅡstudy to evaluate the efficacy a...
Status
Unknown
Location
Zhongshan hospital
Start Date
2021-02-01
Trial ID
NCT05023109
Treatments Being Tested
The efficiency and safety of PD-1 inhibitor in combination with venetoclax ...
Status
Recruiting
Location
Xiao-ning Gao
Start Date
2024-07-18
Trial ID
NCT06536959
Treatments Being Tested
To estimate the efficacy and safety of tislelizumab for stage IVA locally a...
Status
Unknown
Location
National Cancer Center /National Clinical Research Center for Cancer/Cancer Hospital, CAMS & PUMC
Start Date
2021-09-01
Trial ID
NCT05448885
Treatments Being Tested
The purpose of this study is to explore the efficacy and safety of a combin...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2021-04-14
Trial ID
NCT04833257
Treatments Being Tested
This study is aimed to evaluate the efficacy and safety of tislelizumab com...
Status
Active Not Recruiting
Location
Chongqing University Cancer Hospital
Start Date
2025-10-04
Trial ID
NCT07248696
Treatments Being Tested
This is a phase II, single-arm, prospective clinical trial designed to eval...
Status
Recruiting
Location
Shandong Cancer Hospital and Institute
Start Date
2025-07-01
Trial ID
NCT07030140
Treatments Being Tested
This trial aim to explore whether short-course tislelizumab (3 cycles of 20...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-15
Trial ID
NCT07373990